An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood.
about
Juvenile idiopathic arthritis-associated uveitisThe role of gender in juvenile idiopathic arthritis-associated uveitisThe Future Is Now: Biologics for Non-Infectious Pediatric Anterior UveitisUveitis in juvenile idiopathic arthritisAssociation of HLA-DRB1*13 with susceptibility to uveitis in juvenile idiopathic arthritis in two independent data sets.A reconsideration of anterior chamber flare and its clinical relevance for children with chronic anterior uveitis (an American Ophthalmological Society thesis).Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients.Juvenile idiopathic arthritis-associated uveitis: Data from a region in western Greece.Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case seriesFavourable outcome after cataract surgery with IOL implantation in uveitis associated with juvenile idiopathic arthritis.The importance of visual function in the quality of life of children with uveitis.Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroidsHigh-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis.Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study.Controversies in juvenile idiopathic arthritis-associated uveitis.Visual loss in uveitis of childhood.The risk of complications of uveitis in a district hospital cohort.Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis.Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritisThe role of sex in uveitis and ocular inflammation.Impact of Juvenile Idiopathic Arthritis Associated Uveitis in Early AdulthoodThe Association of Race With Childhood Uveitis.Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry.Current perspectives on ophthalmic manifestations of childhood rheumatic diseasesPrevention and management of cataracts in children with juvenile idiopathic arthritis-associated uveitisSevere macular edema in patients with juvenile idiopathic arthritis-related uveitisUpdates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).Cutting-edge issues in autoimmune uveitis.Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood.Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors.Pediatric uveitis: new and future treatments.Juvenile idiopathic arthritis-associated uveitis: clinical features and complications, risk factors for severe course, and visual outcome.Judicious use of biologicals in juvenile idiopathic arthritis.Uveitis associated with juvenile idiopathic arthritis.Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis.Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis.Ocular morbidities of juvenile idiopathic arthritis-associated uveitis in adulthood: results from a tertiary center study.Chronic Anterior Uveitis in Children.Pattern of Pediatric Uveitis Seen at a Tertiary Referral Center from India.
P2860
Q26749339-B90E5A71-BE73-4573-89D9-702C3E496ADCQ27010572-81F146E3-8A90-4C43-B18E-5E725E5976D1Q27025862-112BFA33-00BD-43EA-B4F9-45E537CE4301Q28086972-FDA10E78-26C4-4A5D-A73B-6A7E7686EA2EQ31032836-912B1F35-CB05-46A1-9BA0-B73C2475062EQ33329798-EC090668-2617-4851-94A4-CD4638D5434DQ33435733-E9D0582D-7BE2-4A59-944F-36B970C462AAQ33576645-610736EB-7696-4B6A-81A4-15C6A668CE1DQ33712570-B81EB7B8-68E9-4142-846C-98C40E0EF5DEQ33817468-52278020-F835-4F80-ADC4-13E7E8094D83Q33838321-52E89020-3B21-4EFA-8D56-BF3D5F9BBDBBQ33976794-1AFDC629-FE90-4592-A28F-E06CCC182B0AQ34070773-C32A384C-C439-42FC-8CF6-81518CB989FEQ34444734-F6C75072-948C-49B4-9759-FABD8244E3DFQ34742968-513B9FA7-2D58-4A94-A5C1-0A262F4F9E68Q35591193-C7A2CB67-989F-4604-96EE-A5062B6F6F86Q35591926-0A0F9E61-8CCC-418A-B34C-4C535143A548Q35669508-CF50BE4A-1FEB-4653-827D-7C17BD16D6DAQ35843799-A6602CB2-D0A9-4DCF-B0A5-6B40B5A4A015Q35849200-07B2B559-9D40-450F-A9FC-9C4DDF764CCEQ36159528-B75BFD3B-51EB-478D-8F8E-1CE8A8EB3C8EQ36322456-04C00AAA-51C7-4392-95B4-D44FECDF0EFBQ36584169-38EC9F5A-BD09-4F33-BBC2-17CE3DEF7F79Q37007652-DAD064D2-DB7E-475D-B8E7-2BC9BF5F15D3Q37115017-4B2376AF-54FA-424B-9251-B4EB1AD5E453Q37140151-23070CA8-0CDD-4A05-9BF2-8CDC2F7F2B55Q37262587-756A7512-F598-48F1-849F-1B287368E491Q37479820-0ED596D8-9753-4E8D-A9E9-0CE44ED2B96AQ37931096-F20A8B66-419A-461C-89E0-764B5EFA6920Q37995987-4470C807-FD87-44BE-948F-2C621E60A9C3Q38109932-07BC2FFA-9683-400E-840B-F70267612112Q38123032-A8B9E7FE-39A5-4725-AC0F-A36171732F08Q38129935-4865FD95-E22D-4486-B4FB-E703C0A5B18CQ38248905-E8B4CF70-049E-41EB-911B-713D75F1C72BQ38396962-A72160F6-5D90-44B1-8525-060777CBDBCAQ38664517-72A4CD83-DDE2-4136-A4CA-8EEAE5EF1A2DQ39336335-1BFFFA0B-D875-4056-A8CA-D8FAD09E829AQ39847023-A38FF69C-B696-453A-AF68-A2680B22A9D7Q40748525-BFABD0F8-52C4-4E63-A824-2EA732836580Q41109814-784E1552-86CE-49B7-AA3D-384C7FFB5EC1
P2860
An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
An evaluation of baseline risk ...... or uveitis in early childhood.
@ast
An evaluation of baseline risk ...... or uveitis in early childhood.
@en
An evaluation of baseline risk ...... or uveitis in early childhood.
@nl
type
label
An evaluation of baseline risk ...... or uveitis in early childhood.
@ast
An evaluation of baseline risk ...... or uveitis in early childhood.
@en
An evaluation of baseline risk ...... or uveitis in early childhood.
@nl
prefLabel
An evaluation of baseline risk ...... or uveitis in early childhood.
@ast
An evaluation of baseline risk ...... or uveitis in early childhood.
@en
An evaluation of baseline risk ...... or uveitis in early childhood.
@nl
P2093
P2860
P356
P1476
An evaluation of baseline risk ...... or uveitis in early childhood.
@en
P2093
Christopher R Bentley
Elizabeth M Graham
Jack J Kanski
Vickie Lee
P2860
P356
10.1136/BJO.86.1.51
P407
P577
2002-01-01T00:00:00Z